Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers, Beta-Blockers or Both in Incident End-Stage Renal Disease Patients Without Cardiovascular Disease: a Propensity-Matched Longitudinal Cohort Study
AuthID
P-00Q-V99
P-00Q-V99